MAPT and Alzheimer disease: Previous work has found that disrupted brain grey matter (GM) network measures, reflecting covariance patterns in GM morphology, are related to increased risk of cognitive decline and progression to Alzheimer’s disease dementia.7–10 Across those studies, disrupted whole-brain network measures gamma (i.e. normalized values of the clustering coefficient) and small-world, i.e. indicative of an increasingly random network and reduction in small-world organization, were most robustly associated with cognitive decline, adding information to hippocampal volume (HV) and/or CSF tau measures.